The influence of information on drug resistance on protocol design.
DeVita
V T
VT
Memorial Sloan-Kettering Cancer Center, New York, N.Y.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic / Q000379:methods; D004334:Drug Administration Schedule; D004351:Drug Resistance; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012107:Research Design